Jump directly to page content
Link to homepage GARBE Institutional Capital
Science & Technology

Investing in future innovations

Europe stands at the outset of a decade of rapid growth in areas where scientific knowledge can be transformed into real products and services. Based on this conviction, we were among the first investment managers to initiate a strategy specifically for assets designed to serve the needs of R&D focused companies and institutions. We invest capital where our future is defined. Our Science & Technology Real Estate strategy covers the fields of (bio)pharmaceutics, medical technology, bioinformatics, information technology, aerospace and Industry 4.0, among others. Due to our long-term investment focus, we know that flexibility  and third-party utilisation are key acquisition criteria.

GARBE Institutional Capital is a fully integrated real estate investment manager with excellent market access, building the bridge between institutional investors and long-term sustainable property values.

As a fully integrated manager we serve our clients throughout the entire property value chain. We initiate and structure regulated property funds as well as separate accounts and create value through active management, development and refurbishment of our assets.

With our pan European real estate platform which has offices in Hamburg, Frankfurt am Main, Cologne, Amsterdam, Prague, Milan, Madrid, Paris and London, we have more than 55 years experience in developing and managing real estate.


Usage Type Science & Technology properties are characterised as a mixture of production, laboratory and R&D facilities as well as storage and office space
Countries/ Regions Germany, The Netherlands, France, United Kingdom, Central Eastern Europe
Macro Location Metropolitan areas (esp. A- and B-cities)
Micro Location Situated in established and innovative R&D and industry clusters
Proximity to research institutes, universities or hospitals
Tenants Single- and multi-tenant
Tenants from the sciences segment (e.g. medical science, pharmaceutical or biotech)
Tenants from the technology segment (e.g. information technology, aerospace, industry 4.0)
Property Newly developed and existing buildings
Developments / redevelopments
Greenfield / brownfield sites
Deal Structure Asset and share deals
Forward deals and forward fundings
Leasehold / freehold
Investment Volume >EUR 15 million for single assets
Please direct your inquiries or offers to investment.gain@garbe.de or get in touch with our local contacts.

Contact us

Andreas Höfner

Managing Director | Head of Germany | Head of Research & Strategy

Remco van der Mije

Fund Manager Science & Technology Real Estate | Senior Investment Manager

Links to social networks